The ionophore monensin inhibited the formation of herpes simplex virus type 2 (HSV-2) particles by about 30~ but the yields of infectious particles were reduced to 5~ and 1 ~ for cell-associated and extracellular virus, respectively. The presence of monensin did not affect the processing of the two viral glycoproteins gB-2 and gG-2. However, two other glycoproteins, gC-2 and gD-2, were not processed to their fully mature forms in the monensin-treated cells and only the faster moving pgC-2 and pgD-2 were detected. The cell-associated virus particles contained the glycoproteins gB-2, gC-2, gD-2 and gG-2, whereas the extracellular virus particles contained only gG-2 glycoprotein. These results suggest that HSV
INTRODUCTION
Herpes simplex virus (HSV) buds from the inner membrane of the nuclear envelope (Darlington & Moss, 1968) . The membranes of the virions and infected cells contain a number of virus-specified glycoproteins which contain N-and/or O-glycosylated oligosaccharides (Spear, 1985) . The two common types of HSV, facial (HSV-1) and genital (HSV-2) are closely related (Person et al., 1985) . The genes of four antigenically distinct glycoproteins gB, gC, gD and gE map colinearly in the HSV-1 and HSV-2 genomes (Spear, 1985) . The glycoprotein gG-2 encoded by the S component of the HSV-2 genome (Marsden et al., 1984) also has a smaller sized counterpart mapped in the US4 region of the HSV-1 genome (Frame et al., 1986; Richman et al., 1986) . The HSV-1 glycoproteins have been studied extensively to elucidate their biogenesis, glycosylation, processing and intracellular transport (Spear, 1985) . The genes for the glycoproteins gB-1, gC-1, gD-1 and gE-1 have also been cloned and sequenced and the deduced amino acid sequences have been reported (Bzik et al., 1984; Frink et al., 1983 : McGeoch et al., 1985 Watson et al., 1982) . However, the glycoproteins of HSV-2 have not been studied as extensively. The kinetics of synthesis of gB-2, gC-2, gD-2, gE-2 and gG-2 proteins have been studied in virus-infected cells (Balachandran et al., 1982) and the sequences of the genes encoding gB-2 (Bzik et al., 1986) , gC-2 (Swain et al., 1985) and gD-2 (Watson, 1983) have recently been determined.
In an HSV-infected cell the viral glycoproteins are targeted to two separate destinations. Viral glycoproteins are transported to the inner membrane of the nuclear envelope where the virus particles bud (Darlington & Moss, 1968) . Nuclei isolated from HSV-l-infected cells have been shown to contain increased amounts of the immature forms of the glycoproteins gB-1, gC-1 and gD-1, suggesting that the newly synthesized glycoproteins migrate to the inner nuclear membrane for virus envelopment and budding (Compton & Courtney, 1984) . Some viral glycoproteins are also targeted to the host cell plasma membrane where they are involved in virus pathogenesis and protective immune responses (Spear, 1985) .
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The monovalent cation ionophore monensin has been extensively used to study the processing of glycoproteins and their trafficking through the Golgi complex (Ki~iiri~iinen et al., 1980; Kuismanen et al., 1985; Tartakoff, 1983) . In HSV-l-infected cells, monensin was reported to inhibit the processing of the viral glycoproteins and their transport to the cell surface (Johnson & Spear, 1982) . The release of virion particles was also significantly blocked in the presence of this ionophore (Johnson & Spear, 1982) . Here we report the effect of monensin on the synthesis, processing and transport of HSV-2 glycoproteins and on the production and release of infectious virus particles. The results show that although the processing of gC-2 and gD-2 was affected in the presence of monensin, gB-2 and gG-2 were processed normally. Production of infectious particles was drastically reduced in the presence of monensin. However, significant amounts of non-infectious particles were observed both intracellularly and extraceUularly. In contrast to the intracellular particles which contained gB-2, gC-2, gD-2 and gG-2, the extracellular noninfectious particles contained only gG-2 glycoprotein.
METHODS

Cells and virus.
BHK and Vero cells were grown as monolayer cultures in high glucose Dulbecco's medium supplemented with 7~ foetal bovine serum or 10~ calf serum (Gibco). The virus strain used was HSV-2 (strain 333) and was obtained from Dr S. Bacchetti, Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Materials. Monensin (Calbiochem-Behring) stock solution was made in absolute ethanol at a concentration of 20 mi.
[35S]Methionine (sp. act. 900 to 1100 Ci/mmol) was purchased from New England Nuclear. Endo-fl-Nacetylglucosaminidase-H (Endo H) was a generous gift from Dr P. Robbins, MIT, Boston, Mass., U.S.A. The monoclonal antibodies used were 20or D4, 17ct C1, 18fl B3, 17fl C2 and 13ct C5 recognizing gB-2, gC-2, gD-2, gE-2 and gG-2 glycoproteins, respectively (Balachandran et al., 1982) . These were kindly provided by Dr N. At 5 h post-infection (p.i.) [35S] methionine was added at 25~Ci/ml and labelling was carried out until 18 h p.i. or as described in the text. For pulse-chase experiments, the infected cells were pulse-labelled at 5 h p.i. with [aSS]methionine (50~tCi/ml) for 15 rain and chased with 100-fold excess non-radioactive methionine. The radioactive proteins were immunoprecipitated as described by Rose & Bergmann (1982) . Cells were pre-treated with 1 ktM-monensin for 2 h and [35S]methionine (25 ~tCi/ml) was added to the infected cells at 5 h p.i. in the presence of 1 ~tM-monensin and the cells were labelled till 21 h p.i. At 21 h p.i. the medium was removed for extracellular virus purification. For isolation of intracellular virus particles, infected cells were sonicated and clarified by centrifugation at 3000 r.p.m, for 10 rain. Both the medium and the clarified extract were layered separately onto 20 to 60~ sucrose gradients and were centrifuged at 40000 r.p.m, for 1 h in a SW40 rotor. The virus-containing fractions were pooled. Samples of the viral fraction were used to determine infectivity by plaque assay on Vero cell monolayers.
Electron microscopy. Veto cell monolayers were infected with HSV-2 at a m.o.i, of 10 p.f.u./cell in the presence or in the absence of 1 p,M-monensin. At l0 to 14 h p.i. the infected cells were fixed for 30 rain at 4°C using a solution of 1 ~ paraformaldehyde and 2 ~ glutaraldehyde. The fixed cells were processed and photographed as described by Bergeron et al. (1982) .
RESULTS
Effect of monensin on production of infectious virus
The effect of monensin on the total number of virus particles formed was determined by the amount of radioactivity present in [35S]methionine_labelled intracellular and extracellular virus fractions purified by sucrose density gradient centrifugation (Fig. 1) . Fractions containing HSV-2 particles were pooled and a sample was assayed for infectivity of the virus particles formed in the presence or in the absence of monensin. Results presented in Table 1 show that monensin inhibited the formation of intracellular virus particles by 7~o whereas the infectious virus particle formation was reduced by 95 ~. The number of extracellular virus particles released in the medium was decreased by 37 ~o in the presence of monensin whereas infectious extracellular virus particle formation was reduced by 99~. These data suggest that monensin drastically reduces the infectivity of the virus particles without markedly affecting the envelopment of the nucleocapsids. The electron micrographs of HSV-2-infected cells in the presence and in the Released in medium 2.5 x l0 s 1.6 x 105 37-3 2.7 x 106 1.5 × 104 99 * Hot TCA-precipitable radioactivity of pooled fractions of sucrose density gradient-purified virus (Fig. 1) . Fractions 18 to 23 were pooled for cell-associated particles and fractions 19 to 22 or 20 to 23 were pooled for viruses released in the absence or in the presence of 1 I~M-monensin (Mon) respectively. t Percent reduction is that caused by 1 ~tM-monensin.
absence of monensin (Fig. 2) further show that the envelopment of HSV-2 nucleocapsids does take place in the presence of monensin.
Characterization of glycoproteins incorporated in HSV-2 in the presence of monensin
Purified [3SS]methionine-labelled cell-associated and extracellular virus particles were analysed for the glycoproteins incorporated in them in the absence and in the presence of monensin. Four HSV-2-specific glycoproteins, gB-2, gC-2, gD-2 and gG-2 were analysed using corresponding monoclonal antibodies. The cell-associated virus particles synthesized either in the presence or in the absence of monensin contained all four glycoproteins (Fig. 3) . The gB-2 Fig. 2 . Electron micrographs of virus particle envelopment at the inner nuclear membrane (a) in the absence or (b) in the presence of 1 ~tM-monensin. present in virus particles synthesized in the presence of monensin showed a decreased mobility compared to the mobility of gB-2 present in virus particles that were synthesized in the absence of the drug (Fig. 3, lanes 1,2) . The two glycoproteins gC-2 and gD-2 showed faster mobilities in the viruses formed in the presence of monensin (Fig. 3, lanes 5, 7) compared to those formed in the absence of monensin (Fig. 3, lanes 6, 8) . No change in the mobility of gG-2 was detected in the presence of monensin (Fig. 3, lanes 3, 4) . In contrast, the extraceUular virus particles obtained in the presence of monensin contained only gG-2 (Fig. 4, lane 4) . No detectable amounts of gB-2, gD-2 and gE-2 were observed after prolonged exposure of the autoradiogram. 
Processing o f the viral glycoproteins in the presence o f m o n e n s i n
In order to study the effect of monensin on the synthesis and maturation of the HSV-2 glycoproteins the infected BHK cells were pulse-labelled for 15 min at 5 h p.i. ; the radioactive proteins were chased for 1.5 h or 3 h and immunoprecipitated with monoclonal antibodies specific for gB-2, gC-2, gD-2, gE-2 and gG-2 ( Fig. 5 and 6) . No difference in the processing of gG-2 and gB-2 was observed in the presence and in the absence of monensin (Fig. 5b and c,  respectively) . However, the processing of gD-2, gC-2 and gE-2 were distinctly different in the presence of the ionophore (Fig. 5a, 6a and b, respectively) . In the absence of monensin, the pulse-labelled precursors of these three glycoproteins were processed to slow migrating diffuse bands whereas no such changes were detected in the presence of monensin. The glycoproteins of HSV-2, like those of other enveloped viruses, contain N-linked complex type oligosaccharide chains, the processing of which involves the Golgi apparatus. It has been reported that the trimming of the core oligosaccharides of the N-linked sugar chains involve a specific mannosidase localized in the Golgi membrane (Kornfeld & Kornfeld, 1985) . This specific trimming is followed by the addition of terminal sugars in the Golgi apparatus (Kornfeld & Kornfeld, 1985) . These modifications account for the difference in mobilities of these glycoproteins at various stages of their maturation. Endo H specifically cleaves N-linked oligosaccharides containing core high mannose residues whereas the sugar chains processed by the Golgi enzymes are not affected (Kornfeld & Kornfeld, 1985) . We have characterized the oligosaccharide chains of the glycoproteins synthesized in the presence of monensin by their sensitivity to Endo H digestion. The glycoproteins (gB-2, gC-2, gD-2 and gG-2) were immunoprecipitated from intracellular viruses formed in the presence of monensin and were digested with Endo H. The glycoproteins gB-2, gC-2 and gD-2 synthesized in the presence of monensin were sensitive to Endo H digestion (Fig. 7a and c) . The glycoprotein gG-2, present either in the intracellular or in the extracellular virus particles synthesized in the presence of monensin, were found to be completely resistant ( Fig. 7b and e) . The apparently anomalous mobility of gB-2 shown in Fig. 3 (lanes 1 and 2) and 7(a) in the presence and in the absence of monensin (lanes 3 and 1, respectively) led to an interesting observation. It had been demonstrated earlier that, because of the presence of a trypsin-like enzyme activity in Vero cells, the gB made in HSV-I-or HSV-2-infected Vero cells, undergoes proteolytic cleavage to give a faster migrating form of gB-1 (123 000 Mr compared to 133 000 Mr in HEp2 cells) along with a number of lower mol. wt. bands (40 000 Mr to 25 000 Mr) (Pereira et al., 1981 (Pereira et al., , 1982 . The results shown in Fig. 3 and 7(a) confirm the earlier observations (Pereira et al., 1981 (Pereira et al., , 1982 that in the Vero cells the observed size of gB-2 protein is smaller than the actual size. However, in the presence of monensin a single band of gB-2 having a slower mobility was observed (Fig. 7 a, lane  3) . Thus, the trypsin-like activity present in the Vero cells may be inhibited in the presence of monensin. CI C2 P* Ci c2 Fig. 5 . Processing of (a) gD-2, (b) gG-2, (c) gB-2, in monensin-treated cells. BHK cells, not treated ( -) or treated with 1 IxM-monensin (+) were pulse-labelled with [35S]methionine for 15 min (P) and were chased for 1.5 h (C1) and 3 h (C2). The cell lysates were immunoprecipitated with monoclonal antibodies against (a) gD-2, (b) gG-2 and (c) gB-2 and the proteins were analysed on a 10~ SDSpolyacrylamide gel.
DISCUSSION
Previous studies on the effect of monensin on HSV-1 replication and glycoprotein maturation and transport have shown that the inhibitor blocks both the maturation of the HSV-1 glycoproteins as well as transport of the virus to the cell surface (Johnson & Spear, 1982) . Thus, in the presence of 1 ~ti-monensin the yield of both intracellular and extracellular infectious virus particles are reduced by 99.98~ and 8 9~ respectively (Johnson & Spear, 1982) . Electron microscopy revealed that in the presence of monensin virion particles accumulate in intracellular vacuoles but not on the cell surface (Johnson & Spear, 1982) . Our studies with HSV-2, however, show that production of HSV-2 particles was not significantly decreased in the presence of monensin. The yields of cell-associated and extracellular virus were reduced by 7.8 ~o and 37 ~ respectively in the presence of 1 ~tu-monensin. In contrast to the HSV-l-infected cells, monensin reduced the yields of extracellular infectious HSV-2 more significantly. The yields of extracellular and intracellular infectious virus particles were reduced by 9 9~ and 95~, respectively.
In the case of HSV-1 glycoproteins monensin inhibited the processing of the Endo H-sensitive high mannose core oligosaccharide to the Endo H-resistant complex type as well as the Oglycosylation (Johnson & Spear, 1983) . Our results showed that the glycoproteins of HSV-2 are affected by monensin in a more selective way. Thus, the processing ofgC-2, gD-2 and gE-2 to the mature form was inhibited by monensin. Both gC-2 and gD-2 proteins synthesized in the presence of monensin were found to contain Endo H-sensitive high mannose oligosaccharide residues. The processing of the two glycoproteins gB-2 and gG-2 were, however, unaffected in the presence of monensin and gG-2 synthesized in the presence of monensin was Endo Hresistant. Recent studies on the processing of gG-2 have shown that monensin does not inhibit the processing of this glycoprotein (Balachandran & Hutt-Fletcher, 1985) These studies on the synthesis and processing of gG-2 in HSV-2-infected B HK-21 cells have indicated that the Endo H-sensitive precursor of 120000 Mr is processed to the mature gG-2 protein of 108000 Mr (Balachandran & Hutt-Fletcher, 1985) . During a short pulse in the absence of monensin, a minor protein band of 74000Mr was also observed in BHK-21 cells infected with HSV-2 (Balachandran & Hutt-Fletcher, 1985) . In the presence of monensin two Endo H-sensitive proteins of 120 000 Mr and 74000 Mr initially observed were converted into an Endo H-resistant 110000 to 116000 Mr protein (Balachandran & Hutt-Fletcher, 1985) . It was suggested that the 74 000 Mr glycoprotein was generated by proteolytic cleavage of the 120 000 Mr precursor of gG-2 (Balachandran & Hutt-Fletcher, 1985) . Our finding that in the presence of monensin the gG-2 protein synthesized was resistant to Endo H digest-ion is thus in agreement with the previous report (Balachandran & Hutt-Ftetcher, 1985) . A minor band in the region of 75000 Mr was observed both in the presence and absence of monensin during the pulse-labelling and 1.5 h chase periods (Fig. 5b, lanes 1, 2, 4 and 5) and thus could correspond to the 74000Mr intermediate reported eartier (Balachandran & Hutt-Ftetcher, 1985 ). An examination of the polypeptide composition of the labelled intracellular and extracellular virus particles formed in the presence of monensin showed that the intracellular virus particles contained all of the HSV-2-specific glycoproteins. The virus particles released in the presence of monensin on the other hand contained only mature gG-2. These results suggest that incorporation of the immature glycoproteins synthesized in the presence of monensin in the virus particles was not sufficient for their transport and release. On the other hand, the maturation of the glycoproteins could be inhibited due to a block of transport and release of HSV-2 particles. In contrast, the presence of mature gG-2 protein was sufficient to transport and release a significant amount of non-infectious HSV-2 into the medium. The results further suggest that gG-2 may mature by a different mechanism. In fact, it was shown that the maturation and transport to the cell surface of the glycoproteins G 1 and G2 of Uukuniemi virus . Endo kl sensitivity of (a) gB-2, (c, lanes 3 and 4) gC-2, (c lanes I and 2; d) gD-2 and (b; e) gG-2 formed in the absence (CON) or presence (MON) of I ~M-monensin. Intracellular (a to d) and extracellular (e) viruses were purified by sucrose density gradient and were immunoprecipitated with monoclonal antibodies against gB-2, gC-2, gD-2 and gG-2. The immunoprecipitated proteins were treated (lanes 2 and 4) with Endo H or were left untreated (lanes 1 and 3) and were subsequently analysed by SDS-PAGE. is shown on the left hand side.
q~ ~D was not affected in the presence of monensin although virus maturation was effectively blocked (Kuismanen et al., 1985) . The gG-2 may be transported to the plasma membrane via an alternate pathway that is unaffected by monensin. This glycoprotein has been reported to be secreted into the medium of HSV-2-infected cells (Balachandran & Hutt-Fletcher, 1985; Marsden et al., 1984 ; N. GhoshChoudhury & H.P. Ghosh, unpublished observation). In fact, in HSV-2-infected cells, gG-2 is the major secreted glycoprotein (N. Ghosh-Choudhury & H. P. Ghosh, unpublished observation). Thus, in the presence of monensin the gG-2 located on the plasma membrane could re-envelop cytoplasmic nucleocapsids of HSV-2. The re-envelopment of HSV nucleocapsids at cytoplasmic membranes has been proposed previously (Epstein, 1962) . The virus particles that budded from the plasma membrane and contained only gG-2 were, however, non-infectious due to the absence of other HSV glycoproteins which are involved in adsorption, penetration and fusion.
